Spadrot-M 80mg/250mg Tablet
Marketer
Deys Medical
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Spadrot-M 80mg/250mg Tablet
Abdominal discomfort is effectively managed by the combined-action formula in GastroMend 80mg/250mg tablets. This medication alleviates pain, bloating, and cramping by relaxing gastrointestinal muscles and inhibiting pain-signaling chemicals. GastroMend 80mg/250mg tablets should be taken with food, following your doctor's prescribed dosage and duration. Treatment adherence is crucial; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your physician of all concurrent medications, as interactions are possible. Common, typically transient side effects include nausea, vomiting, diarrhea, stomach pain, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and drowsiness are potential effects; avoid driving or tasks demanding concentration until their impact is assessed. Alcohol consumption should be avoided due to potential dizziness exacerbation. Consult your doctor prior to use if pregnant, planning pregnancy, breastfeeding, or if you have liver or kidney disease to ensure appropriate dosage.
Uses of Spadrot-M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Spadrot-M 80mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the 80mg/250mg Spadrot-M tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Spadrot-M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Spadrot-M 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Spadrot-M 80mg/250mg Tablet should be administered with a meal.
How Spadrot-M 80mg/250mg Tablet works:
Combiflam-D, an 80mg/250mg tablet, merges Drotaverine and Mefenamic Acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets and reduces abdominal muscle spasms. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits the production of pain and inflammation-inducing substances within the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Combining Spadrot-M 80mg/250mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Spadrot-M 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Spadrot-M 80mg/250mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Spadrot-M 80mg/250mg Tablets, a potential side effect being dizziness.
KidneyCAUTION
Patients with impaired kidney function should use Spadrot-M 80mg/250mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Spadrot-M 80mg/250mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Spadrot-M 80mg/250mg tablets. Dosage modification of Spadrot-M 80mg/250mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Spadrot-M 80mg/250mg Tablet :
Should you forget to take a Spadrot-M 80mg/250mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Spadrot-M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently